After success of its feasibility research trial, ITGI is commencing the next stage of its research in order to receive regulatory approval for its stents in brain markers.
Stent company ITGI Medical Ltd. (TASE:ITGI) today announced that following the success of its feasibility research trial, it is now commencing the next stage of its research in order to receive regulatory approval for its stents in brain markers.
Research will involve closing aneurysms, treating fistula in the venous arteries, treating arterial walls, sleep arteries, and the vertebrae leading to the brain. Correct treatment of these problems can be life saving, and prevent problems such as blocking the blood flow and clotting in arteries.
Published by Globes, Israel business news - www.globes-online.com - on April 5, 2011
© Copyright of Globes Publisher Itonut (1983) Ltd. 2011